THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 125 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,215,000 | -94.0% | 119,854 | -94.7% | 0.02% | -94.6% |
| Q2 2022 | $20,326,000 | +60.3% | 2,243,473 | +69.1% | 0.31% | +51.9% |
| Q1 2022 | $12,683,000 | +99.6% | 1,326,653 | +130.7% | 0.21% | +126.4% |
| Q4 2021 | $6,355,000 | -56.6% | 575,113 | -70.9% | 0.09% | -61.9% |
| Q3 2021 | $14,646,000 | +169.0% | 1,979,130 | +427.9% | 0.24% | +134.3% |
| Q2 2021 | $5,444,000 | – | 374,912 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |